Archive for the 'Technology' Category

CLiDE – making chemical information a lot more accessible

Wednesday, January 27th, 2010

<meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.2in">As scientists we all learn to cope with ever growing amounts of information, coming from various sources. Scientific information, as virtually all types of information, is predominantly delivered in electronic formats – journal articles, patents, e-books, wiki pages, blogs, etc. We need this information to be readily accessible, and searchable, we archive it on our personal PCs, and on our organization’s servers and knowledge bases. As chemists, we have wonderful visualization techniques that allow us to sift through incredible amount of data, and information, but exactly in this place, there is a strong disconnect between the availability of information and its accessibility. 2D images of molecules are so pivotal to the way we digest chemistry, and yet, as images they are not too prone to our data mining tools. It would be great if publishers of chemistry articles were to retain the original structures in their electronic documents and there is no doubt that this will happen some time in the future.  But, for now, we need a tool which can translate chemistry images into a connection table format which could allow integration of data from the literature into existing chemistry software.</p> <p align="justify" style="margin-bottom: 0.2in">CLiDE is an optical chemical structure recognition engine. It extracts connection tables of molecules from 2D images in various formats: PDF, postscript, JPEG, BMP, PNG, and TIFF. CLiDE has been around for some time now, but in the last two years it finally got the development boost it deserved, in order to make it a cool and useful instrument for every chemist’s toolkit.  It is now equipped with a sleek GUI that can be used to read .pdf as well as a  variety of image file formats.  Any time you come across a structure of interest,  simply select it, extract it, and save it, or send it to your favourite chemical editor (currently ChemDraw, ISISDraw and SymyxDraw are supported). We all know the feeling of  looking at a page full of structures that are  relevant to our work, and would like to  transfer them to another application such as an Excel spreadsheet or a docking program  but redrawing them using a graphic editor is tedious and prone to mistakes. CLiDE takes  away this hassle. It comes in three flavours that can either process a single image  at a time (standard), a whole document at a time (professional), or a full library of documents in one go (batch).</p> <p align="justify" style="margin-bottom: 0.2in">Below you’ll find a demo clip of the new CLiDE product, please contact us to obtain a password to watch it.</p> <p align="justify" style="margin-bottom: 0.2in"><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html" /></p> <p><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html"> </a></p> <div style="text-align: center"><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html"><img align="middle" title="CLiDE clip" alt="CLiDE clip" src="http://www.simbiosys.com/clide/movie_icon.jpeg" /><br /> </a></div> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2010/01/27/clide-making-chemical-information-a-lot-more-accessible/#comments" title="Comment on CLiDE – making chemical information a lot more accessible">1 Comment »</a></p> </div> <div class="post"> <h3 id="post-86"><a href="http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/" rel="bookmark" title="Permanent Link to ARChem 2009.1 is released">ARChem 2009.1 is released</a></h3> <small>Thursday, December 10th, 2009</small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in">2009 has been a year of major progress for ARChem, and the system has hit a number of significant milestones that secured its leading position in the field. We wanted to share a few of our achievements, and to extend our gratitude to many users whose comments have made an impact on the system.</p> <ol> <li> <p align="justify" style="margin-bottom: 0.08in">Chemistry – Several changes to chemical perception algorithms have been implemented. They improve the way target molecules are being addressed, and the way reaction rules are being extracted and clustered from reaction databases. Those improvements have made a small set of manually coded reaction rules obsolete, and have enhanced the system’s capability to deal with some of the challenging aspects of organic synthesis such as chemical interference, stereochemistry and regioselectivity.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Data – As a knowledge-based system, ARChem is highly dependent on the quality and quantity of reactions data encapsulated in commercial databases. We are therefore grateful and proud to have further tightened our relationships with two leaders of the chemical information publishing industry: Elsevier and Symyx. Both CrossFire Beilstein, and Cheminform databases have been fully integrated into the system. Covering a vast spectrum of chemical reactions and offering valuable supporting information through the system.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Breaking up starting materials – The search down a branch of the retrosynthetic tree stops whenever a starting material from the educts database is found. Sometimes it is desirable to break such compounds to even simpler precursors, since they are expensive to purchase, not in stock, etc. The user can now exclude starting materials matching the target molecules, and find synthetic routes to those compounds.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Viewing solutions – The ability to browse through the manifold of generated solutions has been dramatically improved by a synoptic view of reaction steps. The user can see a “preview” of the various solutions by inspecting the list of the next proposed precursors, and jump directly to the associated solutions.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">System design – ARChem is now a more complete system which can be used not only as a local installation, but also as an online service. A queueing system, security features, accelerated search times and many other features have upgraded the system performance, accessibility and usability.</p> </li> </ol> <p align="justify" style="margin-bottom: 0.08in">Below is an example for a synthetic route found by ARChem for Maraviroc – an HIV drug that was developed in Pfizer’s labs in Sandwich, UK, and got FDA approval in 2007. ARChem’s solution includes 9 reactions, with 6 steps in the two longest paths. In this case, the retrosynthetic analysis leads all the way back to commercially available starting materials, shown with their corresponding providers and catalog numbers. ARChem supplies a lot more information to complete the experimental details of the synthetic scheme, such as, reaction conditions, bibliographic references, and additional starting materials providers and catalog numbers.</p> <p align="justify" style="margin-bottom: 0.08in"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg" /></p> <p><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a></p> <div style="text-align: center"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"><img alt="Maraviroc Sol#13 with ARChem 2009.1" title="Maraviroc Sol#13 with ARChem 2009.1" src="http://www.simbiosys.ca/blog/images/maraviroc_solution_13_thumb.jpg" /></a></div> <div style="text-align: center">Click on the image to see it full size</div> <p align="justify" style="margin-bottom: 0.08in">The above suggested synthetic route has been generated completely automatically with no user intervention. It is a strong demonstration of the huge potential of this concept, and of the accomplishments so far. We look forward to 2010 with plenty of items in the ARChem pipeline, and we are particularly eager to continue the dialogue with our industrial and academic users – a scientific exchange that guarantees that the development process maintains continuous, rigorous and coherent progress.</p> <p align="justify" style="margin-bottom: 0.08in">posted by Orr Ravitz</p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/#respond" title="Comment on ARChem 2009.1 is released">No Comments »</a></p> </div> <div class="post"> <h3 id="post-85"><a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/" rel="bookmark" title="Permanent Link to eHiTS 2009 as a Blind Docking Tool">eHiTS 2009 as a Blind Docking Tool</a></h3> <small>Tuesday, December 1st, 2009</small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">As the molecular docking paradigm solidifies its status as a significant tool for drug discovery, chemists explore additional applications of the methods in ways that sometime stretch the existing algorithms to their limits. Most docking programs, including eHiTS, have not been designed or optimized to perform blind docking. In structure based drug discovery, the user is typically expected to define, at some level of accuracy, the binding pocket in the target of interest. The binding site is determined either based on known binding modes of ligands as found in crystal structures of complexes, or based on an educated hypothesis. There are cases, however, in which assumptions about the possible locations of binding hot spots are difficult or should be avoided altogether. This is the case, for example, when the existence of secondary binding sites is suspected, or when one would like to screen active ligands and other compounds on a range of targets to estimate the possibility for drug side-effects, toxicity, and other types of biological activities.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The standard eHiTS usage requires a rough definition of the binding pocket. This is done through the clip file. This file should contain at least two sets of coordinates (or two spatial points) that are located in the designated binding pocket. eHiTS then draws a box around those points, expands it to some extent in all directions and places the search grid inside that box. Then, the box is “flooded” with a virtual fluid to detect all the cavities which will define the binding surface. This is a highly automated process, but it still relies on that user-defined clipping. Commonly the native ligand, amino acids from the binding pocket, or a few atoms from either are chosen as a clip file. If eHiTS is run with the -complex option, the native ligand is inferred as the clipping coordinates. However, eHiTS could be used without any clipping. In this case, the entire receptor will be considered for docking. The whole protein will be flooded, and sufficiently deep clefts will be searched on its surface. The final space in which docking will be performed is defined by the interconnected pockets found on the target. The search grid in such scenarios is typically large, and extensive sampling is required. Nevertheless, the computational efficiency of the eHiTS algorithm allows good sampling in reasonable timescales.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">Several eHiTS users expressed specific interest in blind docking in recent months, and therefore we decided to evaluate eHiTS’ performance in this context. We used the set that was used in an earlier blind docking evaluation (</font><a target="_blank" title="Reference 1" href="http://autodock.scripps.edu/resources/science/hetenyi2006b.pdf"><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif">Hetenyi and van der Spoel, </font></u></font><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif"><strong>2006 [1]</strong></font></u></font></a><font face="Liberation Serif, Times New Roman, serif">). We focused on the 43 complexes used in the paper and have not attempted to use the apo structures. 3 codes (1B70, 1FIW and 1QIZ) were left out because of uncertainty regarding the exact structure used in the paper for docking. The default accuracy (3) was used throughout the study. The average blind docking time was 9 minutes per receptor for this set.</font></p> <p align="justify" style="margin-bottom: 0.08in"><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Results</strong></font><font face="Liberation Serif, Times New Roman, serif">:</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">77.5% of the cases gave at least one conformation under 2 </font><font face="Liberation Serif, Times New Roman, serif">Å in the top 10 poses. In the other cases, one accumulative docking round using poses from the first round as clip files produced successful binding modes in the top 5 poses. The top rank pose is in most cases in the correct binding pocket, offering a good starting point for pose refinement.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The table <a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">here</a> details the results for the specific codes. The Job# column describes whether the results were obtained with a single blind docking run, or with 2 cycles. The Rank# and RMSD columns indicate the rank of the first pose under 2 Å and its RMSD from the crystallographic conformation. The last two columns indicate the top-rank and closest poses RMSDs.</font></p> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The blind docking of phenol into insulin (1MPJ) is shown in Picture1 below. The crystallographic pose is shown in cyan, and sample poses are shown in “hot spots” detected during docking. Those poses can be used to clip the receptor in accumulative docking runs in which the sampling is finer, and the binding pockets are better modelled. It should be noted that this code generates an unusually big number (5) of hot spots. In most cases in the set we observed three, two and often one hot spot, manifesting the detection of the correct binding pocket.</font></p> <p><img align="middle" title="1MPJ" alt="1MPJ" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture1.jpg" /></p> <p><em>Picture1: Phenol binding to Insulin.Several potential binding pockets are detected for this small ligand.</em></p> <p>1NGP (N1G9 FAB fragment) is a case where the majority of poses are generated far from the native ligand. Picture 2 below shows that most of the poses are located in the big cavity between chains L and H of the crystal structure. Several poses, however, reproduce the x-ray binding mode (in cyan) with close to 1 Å RMSD.</p> <p><img align="middle" alt="1NGP" title="1NGP" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture2.jpg" /></p> <p><em>Picture2: 2-(4-hydroxy-3-nitrophenyl)acetic acid docked into N1G9 FAB fragment. The majority of poses are located in the big cavity between chains L and H.</em></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Conclusion</strong></font><font face="Liberation Serif, Times New Roman, serif"><strong>s:</strong></font></p> <p>The above results clearly demonstrate the viability of eHiTS as a blind docking tool. In all cases the correct binding pocket has been identified in the top 32 solutions, and in most cases good poses under 2 Å and even 1 Å were found at the top of the generated poses. The conformations may be further refined by clipping the receptor for subsequent runs, and by working at higher accuracies. As always in eHiTS, the jobs are extremely easy to setup with a simple command line, and with no required preparation for the receptor or the ligand. This, and the speed of the calculations make eHiTS a high throughput blind docking solution.</p> <p align="justify" style="margin-bottom: 0.08in"><meta http-equiv="CONTENT-TYPE" content="text/html; charset=utf-8" /><title /><meta name="GENERATOR" content="OpenOffice.org 2.4 (Unix)" /><font face="Liberation Serif, Times New Roman, serif"> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } H2 { margin-bottom: 0.08in } H2.western { font-family: "Liberation Sans", "Arial", sans-serif; font-size: 14pt; font-style: italic } H2.cjk { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } H2.ctl { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } --> </style></font></p> <h2 class="western"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">Reference:</font></font></h2> <ol><font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"></p> <li>Hetenyi, C. Van der Spoel, D.: ”Blind docking of drug-sized compounds to proteins with up to a thousand residues.”;<br /> 2006 Feb 20;580(5):1447-50. Epub 2006 Jan 31.</li> <li><a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">Blind docking results for eHiTS 2009.1</a>, using the test set of Hetenyi et.al.[1]</li> <p></font></font></font></font></font></font></font></ol> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p align="left" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">by Orr Ravitz</font></font></font></font> </font> </font></font> </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a>, <a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="View all posts in tips and hints" rel="category tag">tips and hints</a> | <a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/#respond" title="Comment on eHiTS 2009 as a Blind Docking Tool">No Comments »</a></p> </div> <div class="post"> <h3 id="post-83"><a href="http://www.simbiosys.com/blog/2009/11/24/useful-scripts-available-as-free-download-on-the-simbiosys-website/" rel="bookmark" title="Permanent Link to Useful scripts available as free download on the SimBioSys website">Useful scripts available as free download on the SimBioSys website</a></h3> <small>Tuesday, November 24th, 2009</small> <div class="entry"> <p>We recently posted on the CCL (Computational Chemistry List, see link <a title="CCL posting by Aniko Simon, on Nov 3rd 2009" target="_blank" href="http://www.ccl.net/chemistry/resources/messages/2009/11/03.003-dir/index.html">here</a>), that there are some useful scripts for the molecular modelling Linux / Unix community available for free on our website. Some of these are specific for eHiTS users, some are more general-purpose. They are all available free of charge here: <a target="_blank" href="http://www.simbiosys.ca/download/scripts/index.html">http://www.simbiosys.ca/download/scripts/index.html</a></p> <p>Bookmark the above site, as we’ll keep updating it with more and more scripts. </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a>, <a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="View all posts in tips and hints" rel="category tag">tips and hints</a> | <a href="http://www.simbiosys.com/blog/2009/11/24/useful-scripts-available-as-free-download-on-the-simbiosys-website/#respond" title="Comment on Useful scripts available as free download on the SimBioSys website">No Comments »</a></p> </div> <div class="post"> <h3 id="post-81"><a href="http://www.simbiosys.com/blog/2009/10/15/interesting-read-london-stock-exchange-dumps-windows-for-linux/" rel="bookmark" title="Permanent Link to Interesting read: London Stock Exchange dumps Windows for Linux">Interesting read: London Stock Exchange dumps Windows for Linux</a></h3> <small>Thursday, October 15th, 2009</small> <div class="entry"> <p>ComputerWorld reported on Oct 7th, 2009:</p> <p>When it comes to business computer systems, nothing is more mission-critical than the massive trading software systems that underlie stock markets. A failure of an hour here can mean billions of dollars of lost trades….</p> <p>see article at <a title="LSE dumps Windows for Linux" target="_blank" href="http://blogs.computerworld.com/14876/london_stock_exchange_dumps_windows_for_linux">London Stock Exchange dumps Windows for Linux</a></p> <p>Bottom line, the London Stock Exchange (LSE) had so many troubles and scandals due to software problems (crash, slow etc.) in the past, all related to their Windows 2003-based servers, that they decided to look for a Linux replacement that seems to be more reliable, faster and a lot cheaper solution - their conterpart in the USA - the NYSE - had done so a long time ago.</p> <p>I hope the pharmaceutical companies do not consider their operations less mission critical.</p> <p>posted by: Aniko </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts in General Discussion" rel="category tag">General Discussion</a>, <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/10/15/interesting-read-london-stock-exchange-dumps-windows-for-linux/#comments" title="Comment on Interesting read: London Stock Exchange dumps Windows for Linux">1 Comment »</a></p> </div> <div class="post"> <h3 id="post-80"><a href="http://www.simbiosys.com/blog/2009/07/16/simbiosys-and-symyx-team-up-to-enhance-computer-aided-synthesis-design-capabilities/" rel="bookmark" title="Permanent Link to SimBioSys and Symyx team up to enhance computer aided synthesis design capabilities">SimBioSys and Symyx team up to enhance computer aided synthesis design capabilities</a></h3> <small>Thursday, July 16th, 2009</small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p style="margin-bottom: 0in">The field of computer aided synthetic design is once again capturing the interest of the chemistry community after years of status quo. SimBioSys’ ARChem is delivering one of the most advanced solutions for synthesis design by by exhaustively enumerating routes from readily available (in-house or purchasable) starting materials to the target molecule of interest. The program performs retrosynthetic analysis using reaction rules deduced from an artificial-intelligence (machine learning) generalization of millions of rules in reaction databases. The success or failure of such a machine learning approach depend, in part, on the quality and comprehensive nature of the reaction databases supplied by the user. Therefore, it is with great excitement that we announce a new partnership between <a title="Symyx" target="_blank" href="http://www.symyx.com/">Symyx</a> and SimBioSys under which the <a title="CIRX @ Symyx" target="_blank" href="http://www.symyx.com/products/databases/synthesis/chem-lib/index.jsp">ChemInform Reaction Library (CIRX)</a> will be made available for use in ARChem. CIRX is derived from the well respected journal of current reaction data published by <a title="CIRX @ FIZ Chemie, Berlin" target="_blank" href="http://www.fiz-chemie.de/en/home/products-services/chemical-data/chemische-daten/cheminform-rx.html">FIZ Chemie, Berlin</a>. This database is updated semiannually to keep abreast of the latest developments in organic synthesis, with roughly 60,000 new reactions added every year to a database that already has well over a million reactions. All areas of organic chemistry are abstracted, including heterocyclic,and natural product chemistry, enzymatic processes, and reactions involving new catalysts. The high quality of the CIRX database provides ARChem with a solid basis for the reaction rules, which will be generated from it.</p> <p style="margin-bottom: 0in"> <p style="margin-bottom: 0in">We look forward to integrating Symyx’s database into ARChem, and to the exploration of other areas of common interest.</p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/07/16/simbiosys-and-symyx-team-up-to-enhance-computer-aided-synthesis-design-capabilities/#comments" title="Comment on SimBioSys and Symyx team up to enhance computer aided synthesis design capabilities">1 Comment »</a></p> </div> <div class="post"> <h3 id="post-78"><a href="http://www.simbiosys.com/blog/2009/05/25/ehits-lightning-in-the-ce-news-digital-briefs-today/" rel="bookmark" title="Permanent Link to eHiTS Lightning in the C&E News Digital Briefs today">eHiTS Lightning in the C&E News Digital Briefs today</a></h3> <small>Monday, May 25th, 2009</small> <div class="entry"> <p>It was not even a year ago, when C&EN published an interesting article regarding the world’s fastest computer: “World’s Fastest Computer Debuts” <a target="_blank" title="C&E News June 2008" href="http://pubs.acs.org/cen/news/86/i24/8624notw3.html">http://pubs.acs.org/cen/news/86/i24/8624notw3.html</a><br /> Today the subject was revisited by C&EN’s Digital Briefs section (<a target="_blank" title="C&E News May 25 2008" href="http://pubs.acs.org/isubscribe/journals/cen/87/i21/html/8721sci3.html">http://pubs.acs.org/isubscribe/journals/cen/87/i21/html/8721sci3.html</a> / mirrored on <a target="_blank" title="SimBioSys media page" href="http://www.simbiosys.ca/whatsnew/media.html">SimBioSys media page</a>) when it featured eHiTS Lightning, the docking and screening product of SimBioSys, that is running on that same platform, i.e. IBM’s Cell/B.E. chip multiprocessor. The state-of-the-art chip powers the affordable Sony’s PlayStation 3 (PS3), making superfast computing a reality for drug discoverers everywhere at only $400 / machine price. This rapid response to technology paradigm shift is achieved by the technical brilliance of our founder Zsolt Zsoldos and diligent work our excellent programmers.</p> <p>Users around the world have already started using eHiTS Lightning on PS3 clusters, making it truly amazing fast and economic. See quote from Trinity College Dublin, Ireland here:<br /> <a target="_blank" title="User Quotes" href="http://www.simbiosys.ca/support/index.html#quotes">http://www.simbiosys.ca/support/index.html#quotes</a><br /> A technical note about the speedup achieved on the PS3 can be found here:<br /> <a target="_blank" title="eHiTS Technical Notes" href="http://www.simbiosys.ca/ehits/ehits_technical_notes.html">http://www.simbiosys.ca/ehits/ehits_technical_notes.html</a></p> <p>posted by:<br /> Aniko </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/05/25/ehits-lightning-in-the-ce-news-digital-briefs-today/#respond" title="Comment on eHiTS Lightning in the C&E News Digital Briefs today">No Comments »</a></p> </div> <div class="post"> <h3 id="post-77"><a href="http://www.simbiosys.com/blog/2009/05/24/ehits-2009-speed-technical-note/" rel="bookmark" title="Permanent Link to eHiTS 2009 Speed Technical Note">eHiTS 2009 Speed Technical Note</a></h3> <small>Sunday, May 24th, 2009</small> <div class="entry"> <p>Dear friends, colleagues, eHiTS users, fellow dockers, high performance computing lovers:</p> <p>As promised on the CCL (posted by Orr Ravitz on May12th 2009: <a title="Orr Ravitz CCL posting May 12 2009" target="_blank" href="http://www.ccl.net/cgi-bin/ccl/message-new?2009+05+12+010">http://www.ccl.net/cgi-bin/ccl/message-new?2009+05+12+010</a>)<br /> we have now posted our “eHiTS 2009 Lightning” speed-up technical note for you at: <a title="eHiTS Speedup Technical Note" target="_blank" href="http://www.simbiosys.ca/ehits/eHiTS_2009_speed.pdf">http://www.simbiosys.ca/ehits/eHiTS_2009_speed.pdf<br /> </a><br /> This technical note reveals in details how much speedup was gained by porting eHiTS docking engine to the IBM’s Cell/B.E. chip multiprocessor, found in the Sony PlayStation 3 (PS3).</p> <p>There are some other rather informative technical notes about eHiTS docking at: <a title="eHiTS Technical Notes" target="_blank" href="http://www.simbiosys.ca/ehits/ehits_technical_notes.html">http://www.simbiosys.ca/ehits/ehits_technical_notes.html</a></p> <p>Happy reading,<br /> Aniko </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/05/24/ehits-2009-speed-technical-note/#respond" title="Comment on eHiTS 2009 Speed Technical Note">No Comments »</a></p> </div> <div class="post"> <h3 id="post-71"><a href="http://www.simbiosys.com/blog/2009/03/10/drug-design-on-the-playstation/" rel="bookmark" title="Permanent Link to Drug Design on the Playstation">Drug Design on the Playstation</a></h3> <small>Tuesday, March 10th, 2009</small> <div class="entry"> <p>David Bradley posted a great article today regarding “Drug Design on the Playstation”, read all about it <a title="David Bradley's Blog Post" target="_blank" href="http://www.reactivereports.com/chemistry-blog/drug-design-on-the-playstation.html">here</a><br /> <a title="reactive reports, DD on the PS3" target="_blank" href="http://www.reactivereports.com/chemistry-blog/drug-design-on-the-playstation.html">http://www.reactivereports.com/chemistry-blog/drug-design-on-the-playstation.html</a> </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/03/10/drug-design-on-the-playstation/#respond" title="Comment on Drug Design on the Playstation">No Comments »</a></p> </div> <div class="post"> <h3 id="post-70"><a href="http://www.simbiosys.com/blog/2009/02/26/simbiosys-inc-releases-a-new-version-of-ehits/" rel="bookmark" title="Permanent Link to SimBioSys Inc. Releases a New Version of eHiTS">SimBioSys Inc. Releases a New Version of eHiTS</a></h3> <small>Thursday, February 26th, 2009</small> <div class="entry"> <p><strong>TORONTO, ON - 26th Feb 2009:</strong> SimBioSys Inc. announces the release of <a target="_blank" title="eHiTS Lightning 2009" href="http://www.simbiosys.ca/ehits/ehits_newfeatures.html">eHiTS 2009</a> - a new version of its molecular docking and virtual screening software. The new release builds on eHiTS’ strengths of its fine, systematic and exhaustive search algorithm, its automatic protonation state handling, and its unique knowledge-based scoring function. It delivers the following new features:</p> <ul> <li>An average <a title="eHiTS Lightning speed up " target="_blank" href="http://www.simbiosys.ca/ehits/ehits_speed.html">10x hardware-based speedup</a> on IBM’s Cell/B.E. platforms.</li> <li>An <a title="eHiTS Score 2009" target="_blank" href="http://www.simbiosys.ca/ehits/ehits_score.html">improved scoring function</a> up-to-date with the latest experimental data.</li> <li>Scoring function pre-tuned for 500 new protein classes.</li> <li>Dramatically <a title="Binding Affinity Technical Note" target="_blank" href="http://www.simbiosys.ca/ehits/eHiTS_2009_binding.pdf">improved correlation between score and binding affinity</a>.</li> </ul> <p>One of the greatest performance enhanced strategic advantages of this new release is the port of this accurate docking tool to the Cell platform. Molecular docking is often used as a <a title="eHiTS 2009 virtual screening aspect" target="_blank" href="http://www.simbiosys.ca/ehits/eHiTS_2009_screening.pdf">virtual screening method</a> for large libraries of compounds in an effort to identify potent molecules for pharmaceutical purposes. The substantial computational cost of this process has so far required computer clusters of considerable size, but the level of speedup achieved on the Cell processor <span style="font-weight: bold">allows replacing roughly 10 cluster nodes with a single PlayStation 3</span>. “This is a<span style="font-weight: bold"> low-cost and green hardware solution</span> that saves on operational costs like cooling, electricity and space,” says<span style="font-weight: bold"> Zsolt Zsoldos SimBioSys’ chief scientist</span>, “it delivers the same high quality results as traditional platforms, and opens up the virtual screening paradigm to small companies who could not afford the IT infrastructure required for the process”.</p> <p>In addition to the Cell-port, eHiTS’ scoring function has undergone a significant overhaul toward the release. “Our knowledge-based approach mandates keeping pace with the most recent publicly available experimental data”, says Zsoldos, “the new scoring function was trained on thousands of PDB structures as well as on activity and binding affinity data”. The current release offers score weight-sets that were<span style="font-weight: bold"> tuned for 500 new protein classes</span>. eHiTS attempts to classify the user’s targets in one of those families, and to use the appropriate scoring scheme which often provides better correlations of the score with low RMSD ligand-poses and with binding affinity. “These changes were shown to produce cutting-edge performance in enrichment studies, and state-of-the-art binding affinity prediction capability, which are essential to structure-based drug design,” Zsoldos adds.</p> <p>SimBioSys is confident that this release positions the company at the forefront of the molecular docking field. “<span style="font-weight: bold">eHiTS 2009 provides a very powerful drug-discovery tool</span>, and during the development of this version we have laid the foundations for additional improvements that will follow in the coming months”, summarizes Dr. Zsoldos, “In addition, the PlayStation solution directly delivers on two key issues in today’s dire market conditions: <span style="font-weight: bold">significant cost reduction with no compromise to quality</span>, and <span style="font-weight: bold">lower environmental footprint due to lower power consumption</span>.”</p> <p><strong>About SimBioSys:</strong><br /> Privately owned, SimBioSys is a recognized leader in the field of rational drug discovery software. Providing a wide range of software solutions, the company is focused on the development of scientific tools to facilitate the drug discovery process. It retains a constant focus on the innovation of algorithms to provide improved throughput and accuracy in the fields of flexible docking, virtual screening and de-novo structure design. SimBioSys is also a pioneer in the field of computer-aided retrosynthetic analysis where it supports chemists through the challenges of organic synthesis. With attention to detail, ease-of-use and improved productivity, SimBioSys has built a strong reputation of delivering state-of-the-art scientific solutions to biotechnology and pharmaceutical companies.</p> <div style="text-align: center"><img alt="eHiTS Lightning 2009" title="eHiTS Lightning 2009" src="http://www.simbiosys.ca/images/PS3_ehits_lightning-thumb.jpg" /></div> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/02/26/simbiosys-inc-releases-a-new-version-of-ehits/#respond" title="Comment on SimBioSys Inc. Releases a New Version of eHiTS">No Comments »</a></p> </div> <div class="navigation"> <div class="alignleft"><a href="http://www.simbiosys.com/blog/category/technology/page/2/">« Previous Entries</a></div> <div class="alignright"></div> </div> </div> <div id="sidebar"> <ul> <li> <a href="http://www.simbiosys.com"><img src="images/SimBioSysLogo_name_long.gif" width="200" ></a> </li> <li> <form method="get" id="searchform" action="http://www.simbiosys.com/blog/"> <div><input type="text" value="" name="s" id="s" /> <input type="submit" id="searchsubmit" value="Search" /> </div> </form> </li> <li> <form style="border:1px solid #ccc;padding:3px;text-align:center;" action="http://www.feedburner.com/fb/a/emailverify" method="post" target="popupwindow" onsubmit="window.open('http://www.feedburner.com/fb/a/emailverifySubmit?feedId=1550225', 'popupwindow', 'scrollbars=yes,width=550,height=520');return true"><p>Enter your email address:</p><p><input type="text" style="width:140px" name="email"/></p><input type="hidden" value="http://feeds.feedburner.com/~e?ffid=1550225" name="url"/><input type="hidden" value="SimBioSys Blog" name="title"/><input type="hidden" name="loc" value="en_US"/><input type="submit" value="Subscribe" /><p>Delivered by <a href="http://www.feedburner.com" target="_blank">FeedBurner</a></p></form> </li> <!-- Author information is disabled per default. Uncomment and fill in your details if you want to use it. <li><h2>Author</h2> <p>A little something about you, the author. Nothing lengthy, just an overview.</p> </li> --> <li> <p>You are currently browsing the archives for the Technology category.</p> </li> <li class="pagenav"><h2>Pages</h2><ul><li class="page_item"><a href="http://www.simbiosys.com/blog/about/" title="About SimBioSys">About SimBioSys</a></li> </ul></li> <li><h2>Archives</h2> <ul> <li><a href='http://www.simbiosys.com/blog/2010/09/' title='September 2010'>September 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/08/' title='August 2010'>August 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/07/' title='July 2010'>July 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/06/' title='June 2010'>June 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/03/' title='March 2010'>March 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/01/' title='January 2010'>January 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2009/12/' title='December 2009'>December 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/11/' title='November 2009'>November 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/10/' title='October 2009'>October 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/07/' title='July 2009'>July 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/06/' title='June 2009'>June 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/05/' title='May 2009'>May 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/03/' title='March 2009'>March 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/02/' title='February 2009'>February 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/01/' title='January 2009'>January 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2008/12/' title='December 2008'>December 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/11/' title='November 2008'>November 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/10/' title='October 2008'>October 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/09/' title='September 2008'>September 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/08/' title='August 2008'>August 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/07/' title='July 2008'>July 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/06/' title='June 2008'>June 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/05/' title='May 2008'>May 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/04/' title='April 2008'>April 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/03/' title='March 2008'>March 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/02/' title='February 2008'>February 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/01/' title='January 2008'>January 2008</a></li> </ul> </li> <li><h2>Categories</h2> <ul> <li><a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts filed under General Discussion">General Discussion</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/news/" title="View all posts filed under News">News</a> (54) </li> <li><a href="http://www.simbiosys.com/blog/category/science/" title="View all posts filed under Science">Science</a> (35) </li> <li><a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts filed under Software products">Software products</a> (33) </li> <li class="current-cat"><a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts filed under Technology">Technology</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="Tells us tips and hints on how to best use eHiTS, and other SimBioSys tools, to maximize your ROI (return on invested time, money, energy etc.). It’s a must-read!">tips and hints</a> (5) </li> <li><a href="http://www.simbiosys.com/blog/category/uncategorized/" title="View all posts filed under Uncategorized">Uncategorized</a> (1) </li> </ul> </li> </ul> </div> <hr /> <div id="footer"> <!-- If you'd like to support WordPress, having the "powered by" link someone on your blog is the best way, it's our only promotion or advertising. --> <p> SimBioSys Blog is proudly powered by <a href="http://wordpress.org/">WordPress</a> <br /><a href="feed:http://www.simbiosys.com/blog/feed/">Entries (RSS)</a> and <a href="feed:http://www.simbiosys.com/blog/comments/feed/">Comments (RSS)</a>. <!-- 16 queries. 0.405 seconds. --> </p> </div> </div> <!-- Gorgeous design by Michael Heilemann - http://binarybonsai.com/kubrick/ --> </body> </html>